retatrutide type 2 diabetes phase 2 results – The New Weight Loss Helper Retatrutide is a new medication being developed by Eli Lilly to help people lose weight. It's like a super version of drugs such as Ozempic Positive Top-line Results for Retatrutide

Several different types of bowel preparations are currently available, so be sure to ask your colonoscopist about the various options and the risks and benefits of each

A recent Coalition for Health AI study found that 93% of patients reported at least one concern about AI in healthcare, and 51% said it makes them trust healthcare less

The co-injection ensures that the B6 reaches systemic circulation at the same time as the semaglutide, providing nausea coverage right when it is most needed

Pivoting back to the obesity space, a year-long Phase 2 study comparing semaglutide daily to 0.6 mg of liraglutide daily and placebo demonstrated the superiority of semaglutide over liraglutide in all doses above 0.2 mg (NCT02453711)